無料セミナー : 2019年11月19日『手術用ロボット:外科医療におけるトランスフォーメーション』 BIS Research共同開催

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

e薬局の世界市場:薬の種類、製品の種類、地域別予測

Global EPharmacy Market Size study, by Drug Type (Prescription Drugs, OTT Drugs), by Product Type (Skin Care, Dental, Cold Flu, Vitamins, Weight Loss, Others) and Regional Forecasts 2018-2025

発行 Bizwit Research & Consulting LLP 商品コード 871527
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.06円で換算しております。
Back to Top
e薬局の世界市場:薬の種類、製品の種類、地域別予測 Global EPharmacy Market Size study, by Drug Type (Prescription Drugs, OTT Drugs), by Product Type (Skin Care, Dental, Cold Flu, Vitamins, Weight Loss, Others) and Regional Forecasts 2018-2025
出版日: 2019年06月10日 ページ情報: 英文
概要

当レポートでは、世界のe薬局市場を調査し、全体的な市場動向、セグメント別の詳細動向、市場成長への影響要因の分析、競合情勢、主要企業のプロファイルなどを包括的にまとめています。

目次

第1章 エグゼクティブサマリー

  • 市場のスナップショット
  • 主要動向
  • 世界全体およびセグメント別市場推定・予測
    • 薬局の種類別
    • 製品タイプ別
    • 地域別
  • 推定方法
  • 調査の前提条件

第2章 市場の定義と範囲

  • 調査目的
  • 市場定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査期間
  • 通貨換算レート

第3章 市場のダイナミクス

  • シーソー分析
    • 市場成長要因
    • 市場の課題
    • 市場機会

第4章 業界分析

  • ポーターのファイブフォースモデル
    • バイヤーの交渉力
    • サプライヤーの交渉力
    • 新規参入の脅威
    • 代用品の脅威
    • 敵対関係
    • ポーターのファイブフォースモデルへの未来的アプローチ
  • PEST分析
    • 政治的シナリオ
    • 経済的シナリオ
    • 社会的シナリオ
    • 技術的シナリオ
  • バリューチェーン分析
    • サプライヤー
    • 製造業者/サービスプロバイダー
    • 販売代理店
    • 利用者
  • 主な購入基準
  • 規制の枠組み
  • 原価構造分析
    • 原料原価分析
    • 製造原価分析
    • 人件費分析
  • 投資/導入シナリオ
  • アナリストの提言と結論

第5章 薬の種類別市場

  • 市場のスナップショット
  • 市場実績 - 潜在的モデル
  • 主要市場参加企業
  • サブセグメント分析

第6章 製品タイプ別市場

  • 市場のスナップショット
  • 市場実績 - 潜在的モデル
  • 主要市場参加企業
  • サブセグメント分析
    • スキンケア
    • 歯科用
    • 風邪・インフルエンザ
    • ビタミン
    • 減量
    • その他

第7章 地域別市場

  • 地域市場のスナップショット
  • 北米市場のスナップショット
    • 米国
    • カナダ
  • 欧州市場のスナップショット
    • 英国
    • ドイツ
    • フランス
    • その他の地域
  • アジア市場のスナップショット
    • 中国
    • インド
    • 日本
    • その他
  • 中南米市場のスナップショット
    • ブラジル
    • メキシコ
  • その他の地域
    • 南米
    • 中東・アフリカ

第8章 競合他社の情報

  • 企業の市場シェア(データの入手可能性による)
  • トップ市場戦略
  • 企業プロファイル
    • CVS Health Corporation
    • DocMorris
    • Giant Eagle Inc.
    • Rowlands Pharmacy
    • The Kroger Corporation
    • Walmart Stores Inc.

第9章 調査方法

  • 調査方法
    • データマイニング
    • 分析
    • 市場予測
    • 検証
    • 出版
    • 調査の前提条件
図表

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF EPHARMACY MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF EPHARMACY MARKET
  • TABLE 3. EPHARMACY MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. EPHARMACY MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)
  • TABLE 7. EPHARMACY MARKET ESTIMATES & FORECASTS BY DRUG TYPE 2015-2025 (USD BILLION)
  • TABLE 8. EPHARMACY MARKET ESTIMATES & FORECASTS BY DRUG TYPE 2015-2025 (USD BILLION)
  • TABLE 9. EPHARMACY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 10. EPHARMACY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 11. EPHARMACY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 12. EPHARMACY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 13. EPHARMACY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 14. EPHARMACY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 15. EPHARMACY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 16. EPHARMACY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 17. EPHARMACY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 18. EPHARMACY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 19. EPHARMACY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 20. EPHARMACY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 21. EPHARMACY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 22. EPHARMACY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 23. EPHARMACY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 24. EPHARMACY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 25. EPHARMACY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 26. EPHARMACY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 27. EPHARMACY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 28. EPHARMACY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 29. EPHARMACY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 30. EPHARMACY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 31. EPHARMACY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 32. EPHARMACY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 33. EPHARMACY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 34. EPHARMACY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 35. EPHARMACY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 36. EPHARMACY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 37. EPHARMACY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 38. EPHARMACY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 39. EPHARMACY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 40. EPHARMACY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 41. EPHARMACY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 42. EPHARMACY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 43. EPHARMACY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 44. EPHARMACY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 45. U.S. EPHARMACY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 46. U.S. EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 47. U.S. EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 48. U.S. EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 49. U.S. EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 50. CANADA EPHARMACY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 51. CANADA EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 52. CANADA EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 53. CANADA EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 54. CANADA EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 55. UK EPHARMACY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 56. UK EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 57. UK EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 58. UK EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 59. UK EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 60. GERMANY EPHARMACY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 61. GERMANY EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 62. GERMANY EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 63. GERMANY EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 64. GERMANY EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 65. ROE EPHARMACY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 66. ROE EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 67. ROE EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 68. ROE EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 69. ROE EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 70. CHINA EPHARMACY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 71. CHINA EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 72. CHINA EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 73. CHINA EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 74. CHINA EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 75. INDIA EPHARMACY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 76. INDIA EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 77. INDIA EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 78. INDIA EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 79. INDIA EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 80. JAPAN EPHARMACY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 81. JAPAN EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 82. JAPAN EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 83. JAPAN EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 84. JAPAN EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 85. ROAPAC EPHARMACY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 86. ROAPAC EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 87. ROAPAC EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 88. ROAPAC EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 89. ROAPAC EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 90. BRAZIL EPHARMACY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 91. BRAZIL EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 92. BRAZIL EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 93. BRAZIL EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 94. BRAZIL EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 95. MEXICO EPHARMACY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 96. MEXICO EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 97. MEXICO EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 98. MEXICO EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 99. MEXICO EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 100. ROLA EPHARMACY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 101. ROLA EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 102. ROLA EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 103. ROLA EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 104. ROLA EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 105. ROW EPHARMACY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 106. ROW EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 107. ROW EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 108. ROW EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 109. ROW EPHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

List of Figures

  • FIG 1. EPHARMACY MARKET, RESEARCH METHODOLOGY
  • FIG 2. EPHARMACY MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. EPHARMACY MARKET, KEY TRENDS 2016
  • FIG 5. EPHARMACY MARKET, GROWTH PROSPECTS 2017-2025
  • FIG 6. EPHARMACY MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. EPHARMACY MARKET, PEST ANALYSIS
  • FIG 8. EPHARMACY MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. EPHARMACY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 10. EPHARMACY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 11. EPHARMACY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 12. EPHARMACY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 13. EPHARMACY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 14. EPHARMACY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 15. EPHARMACY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 16. EPHARMACY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 17. EPHARMACY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 18. EPHARMACY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 19. EPHARMACY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 20. EPHARMACY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 21. EPHARMACY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 22. EPHARMACY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 23. EPHARMACY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 24. EPHARMACY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 25. EPHARMACY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 26. EPHARMACY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 27. EPHARMACY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 28. EPHARMACY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 29. EPHARMACY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 30. EPHARMACY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 31. EPHARMACY MARKET, REGIONAL SNAPSHOT 2015 & 2025
  • FIG 32. NORTH AMERICA EPHARMACY MARKET 2015 & 2025 (USD BILLON)
  • FIG 33. EUROPE EPHARMACY MARKET 2015 & 2025 (USD BILLON)
  • FIG 34. ASIA PACIFIC EPHARMACY MARKET 2015 & 2025 (USD BILLON)
  • FIG 35. LATIN AMERICA EPHARMACY MARKET 2015 & 2025 (USD BILLON)
  • FIG 36. EPHARMACY MARKET, COMPANY MARKET SHARE ANALYSIS (2016)
目次

Global EPharmacy Market valued approximately USD 38.05 billion in 2017 is anticipated to grow with a healthy growth rate of more than 15.20% over the forecast period 2018-2025. The EPharmacy Market is continuously growing in the global scenario at significant pace. The pharmacy, also popularly known as online pharmacy, or mail-order pharmacy, or Internet pharmacy, is a pharmacy operating via Internet and does the sending of orders to its customers via shipping companies or mail. E-Pharmacies include pharmacy benefit manager. Pharmacy benefit manager is a huge group prescription drug plans administrator. Surge in the number of internet users in both developed and developing countries, enhance access to web-based & online services and surging implementation of E-Prescriptions in Hospitals and diagnostic centers are the substantial driving factors of the market during the forecast period. Moreover, increasing adoption of e-commerce platforms in epharmacy is the major factors that likely to create numerous opportunity in the near future. However, surging number of illegal online pharmacies and low adoption of advanced technology in underdeveloped region are the factors that limiting the growth of the market during the forecast period.

The regional analysis of Global EPharmacy Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share due to increasing adoption of ecommerce, increasing frequency of online orders and rising aging population in the region. Europe is estimated to grow at stable growth rate in the global EPharmacy market over the upcoming years. Further, Asia-pacific anticipated to exhibit higher growth rate / CAGR over the forecast period 2018-2025 owing to presence of large patient base and rising health awareness among people in the region.

The major market player included in this report are:

  • CVS Health Corporation
  • DocMorris
  • Giant Eagle Inc.
  • Rowlands Pharmacy
  • The Kroger Corporation
  • Walmart Stores Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Type:

  • Prescription Drugs
  • OTT Drugs

By Product Type:

  • Skin Care
  • Dental
  • Cold Flu
  • Vitamins
  • Weight Loss
  • Others

By Regions:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • Asia Pacific
  • China
  • India
  • Japan
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year - 2015, 2016
  • Base year - 2017
  • Forecast period - 2018 to 2025

Target Audience of the Global EPharmacy Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

TABLE OF CONTENTS

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Key Trends
  • 1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
    • 1.3.1. Epharmacy Market, by Drug Type, 2015-2025 (USD Billion)
    • 1.3.2. Epharmacy Market, by Product Type, 2015-2025 (USD Billion)
    • 1.3.3. Epharmacy Market, by Region, 2015-2025 (USD Billion)
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Epharmacy Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Epharmacy Market Dynamics

  • 3.1. See Saw Analysis
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Epharmacy Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Buyers
    • 4.1.2. Bargaining Power of Suppliers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.2. PEST Analysis
    • 4.2.1. Political Scenario
    • 4.2.2. Economic Scenario
    • 4.2.3. Social Scenario
    • 4.2.4. Technological Scenario
  • 4.3. Value Chain Analysis
    • 4.3.1. Supplier
    • 4.3.2. Manufacturers/Service Provider
    • 4.3.3. Distributors
    • 4.3.4. End-Users
  • 4.4. Key Buying Criteria
  • 4.5. Regulatory Framework
  • 4.6. Cost Structure Analysis
    • 4.6.1. Raw Material Cost Analysis
    • 4.6.2. Manufacturing Cost Analysis
    • 4.6.3. Labour Cost Analysis
  • 4.7. Investment Vs Adoption Scenario
  • 4.8. Analyst Recommendation & Conclusion

Chapter 5. Epharmacy Market, by Drug Type

  • 5.1. Market Snapshot
  • 5.2. Market Performance - Potential Model
  • 5.3. Key Market Players
  • 5.4. Epharmacy Market, Sub Segment Analysis
    • 5.4.1. Prescription Drugs
      • 5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.4.2. OTT Drugs
      • 5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 6. Epharmacy Market, by Product Types

  • 6.1. Market Snapshot
  • 6.2. Market Performance - Potential Model
  • 6.3. Key Market Players
  • 6.4. Epharmacy Market, Sub Segment Analysis
    • 6.4.1. Skin Care
      • 6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 6.4.2. Dental
      • 6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 6.4.3. Cold Flu
      • 6.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 6.4.4. Vitamins
      • 6.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 6.4.5. Weight Loss
      • 6.4.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.4.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 6.4.6. Others
      • 6.4.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.4.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 7. Epharmacy Market, by Regional Analysis

  • 7.1. Epharmacy Market, Regional Market Snapshot (2015-2025)
  • 7.2. North America Epharmacy Market Snapshot
    • 7.2.1. U.S.
      • 7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.1.2. Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.1.3. Product Types breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.2.2. Canada
      • 7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.2.2. Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.2.3. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.3. Europe Epharmacy Market Snapshot
    • 7.3.1. U.K.
      • 7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.1.2. Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.1.3. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.3.2. Germany
      • 7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.2.2. Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.2.3. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.3.3. France
      • 7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.3.2. Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.3.3. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.3.4. Rest of Europe
      • 7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.4.2. Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.4.3. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.4. Asia Epharmacy Market Snapshot
    • 7.4.1. China
      • 7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.1.2. Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.1.3. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.2. India
      • 7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.2.2. Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.2.3. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.3. Japan
      • 7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.3.2. Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.3.3. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.4. Rest of Asia Pacific
      • 7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.4.2. Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.4.3. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.5. Latin America Epharmacy Market Snapshot
    • 7.5.1. Brazil
      • 7.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.1.2. Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.1.3. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.5.2. Mexico
      • 7.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.2.2. Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.2.3. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.6. Rest of The World
    • 7.6.1. South America
      • 7.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.1.2. Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.1.3. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.6.2. Middle East and Africa
      • 7.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.2.2. Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.2.3. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 8. Competitive Intelligence

  • 8.1. Company Market Share (Subject to Data Availability)
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. CVS Health Corporation
      • 8.3.1.1. Overview
      • 8.3.1.2. Financial (Subject to Data Availability)
      • 8.3.1.3. Summary
      • 8.3.1.4. Recent Developments
    • 8.3.2. DocMorris
    • 8.3.3. Giant Eagle Inc.
    • 8.3.4. Rowlands Pharmacy
    • 8.3.5. The Kroger Corporation
    • 8.3.6. Walmart Stores Inc.

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
    • 9.1.6. Research Assumption
Back to Top